Alnylam Pharmaceuticals, Inc.

Orion Porfolio Solutions, LLC ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

4,405

Value ($000)

1,752

Weight

0.0%

2019 Q4 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	1,752	0.0%	4,405	12/31/2025
2025 Q3	11/12/2025	2,461	0.0%	5,398	9/30/2025
2025 Q2	8/27/2025	1,405	0.0%	4,309	6/30/2025
2025 Q1	8/1/2025	1,041	0.0%	3,857	3/31/2025
2024 Q4	8/1/2025	881	0.0%	3,744	12/31/2024
2024 Q3	7/31/2025	974	0.0%	3,541	9/30/2024
2024 Q2	7/31/2025	749	0.0%	3,084	6/30/2024
2024 Q1	7/31/2025	321	0.0%	2,145	3/31/2024
2023 Q4	7/31/2025	498	0.0%	2,529	12/31/2023
2023 Q3	7/31/2025	458	0.0%	2,585	9/30/2023
2023 Q2	7/31/2025	447	0.0%	2,356	6/30/2023
2023 Q1	7/31/2025	498	0.0%	2,484	3/31/2023
2022 Q4	2/6/2023	597	0.0%	2,512	12/31/2022
2022 Q3	11/1/2022	531	0.0%	2,653	9/30/2022
2022 Q2	7/18/2022	364	0.0%	2,493	6/30/2022
2022 Q1	5/16/2022	453	0.0%	2,774	3/31/2022
2021 Q4	2/8/2022	479	0.0%	2,822	12/31/2021
2021 Q3	11/8/2021	419	0.0%	2,473	9/30/2021
2021 Q2	8/3/2021	419	0.0%	2,473	6/30/2021
2021 Q1	5/12/2021	270	0.0%	1,915	3/31/2021
2019 Q4	2/6/2020	69	0.0%	600	12/31/2019